Onemednet Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 2.61, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Onemednet in Jun 30 2026 quarter, has decreased to 140 days, compared to 162 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 488 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2853 to 3199.

What is Receivable Turnover Ratio?
What is Onemednet Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ONMD Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	161.42 %	182.19 %	132.39 %	823.81 %	238.67 %
Y / Y Revenue Change	-	-	3326.92 %	-13.38 %	-
Receivable Turnover Ratio (TTM)	2.61	2.25	1.17	-	-
ONMD's Total Ranking	# 3199	# 2853	# 2411	# 0	# 0
Accounts Receivable average collection period days	140	162	312	-	-
Seq. Receivable Change	-4.73 %	40.81 %	-14.95 %	129.13 %	2.83 %
Seq. Revenue Change	2.82 %	-68.13 %	624.39 %	-	-

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 29
Healthcare Sector	# 489
Overall Market	# 3199

Receivable Turnover Ratio Statistics
High	Average	Low
10.96	2.28	-1.98
(Sep 30 2024)		(Jun 30 2025)

ONMD Company Profile • Back to ONMD Efficiency Comparisons • Compare ONMD Receivables Turnover Ratio to its Competitors

Financial Statements
Onemednet's Accounts Receivable	$ 1 Millions	Visit ONMD's Balance sheet
Onemednet's Sales TTM	$ 2 Millions	Visit ONMD's Income Statement
Sources of ONMD's Revenues		Visit ONMD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ONMD's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ONMD's Growth Rates	ONMD's Roa	ONMD's Inventory Turnover Ratio	ONMD's Dividend Comparisons
ONMD's Profitability Ratios	ONMD's Roi	ONMD's Asset Turnover Ratio	ONMD's Dividend Growth
ONMD's Valuation Ratios	ONMD's Roe	ONMD's Financial Strength Ratios	ONMD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Pmgc Holdings Inc	6.57	$ 2.579 Millions	$ 0.393 Millions
Embecta Corp	6.50	$ 1,019.700 Millions	$ 156.775 Millions
Moderna Inc	6.49	$ 2,228.000 Millions	$ 343.250 Millions
Cvrx inc	6.44	$ 60.164 Millions	$ 9.345 Millions
Tarsus Pharmaceuticals Inc	6.43	$ 606.331 Millions	$ 94.240 Millions
Haemonetics Corporation	6.42	$ 1,351.722 Millions	$ 210.662 Millions
Ufp Technologies Inc	6.40	$ 632.042 Millions	$ 98.785 Millions
Adaptive Biotechnologies Corporation	6.38	$ 308.081 Millions	$ 48.254 Millions
Iradimed Corporation	6.38	$ 86.339 Millions	$ 13.533 Millions
Edap Tms Sa	6.34	$ 111.051 Millions	$ 17.522 Millions
Syndax Pharmaceuticals Inc	6.32	$ 252.004 Millions	$ 39.902 Millions
Nuwellis Inc	6.28	$ 9.013 Millions	$ 1.435 Millions
Absci Corp	6.24	$ 1.561 Millions	$ 0.250 Millions
Maxcyte inc	6.22	$ 31.051 Millions	$ 4.994 Millions
Cue Biopharma Inc	6.21	$ 37.654 Millions	$ 6.064 Millions
Heartflow Inc	6.20	$ 210.791 Millions	$ 33.999 Millions
Omada Health Inc	6.20	$ 308.445 Millions	$ 49.770 Millions
Vertex Pharmaceuticals Inc	6.19	$ 12,587.200 Millions	$ 2,032.400 Millions
Harvard Bioscience Inc	6.16	$ 88.164 Millions	$ 14.306 Millions
Integra Lifesciences Holdings Corp	6.14	$ 1,647.666 Millions	$ 268.153 Millions
Interpace Biosciences Inc	6.12	$ 36.519 Millions	$ 5.963 Millions
Xeris Biopharma Holdings Inc	6.12	$ 335.414 Millions	$ 54.800 Millions
Treace Medical Concepts Inc	6.12	$ 205.307 Millions	$ 33.551 Millions
Aquestive Therapeutics Inc	6.08	$ 54.087 Millions	$ 8.891 Millions
Femasys Inc	6.08	$ 2.299 Millions	$ 0.378 Millions
Capsovision Inc	5.98	$ 12.804 Millions	$ 2.140 Millions
Sera Prognostics Inc	5.96	$ 0.070 Millions	$ 0.012 Millions
Msa Safety Inc	5.95	$ 1,946.916 Millions	$ 327.189 Millions
Bio techne Corp	5.91	$ 1,213.869 Millions	$ 205.480 Millions
Pacira Biosciences inc	5.90	$ 746.164 Millions	$ 126.498 Millions

Date modified: 2026-08-29T17:43:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.